Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Cohodes Tweet about Phenobarbital
View:
Post by CLtrader1 on Jun 08, 2016 9:01am

Cohodes Tweet about Phenobarbital

Shorts will say whatever they can to defend their position.  See Cohodes tweet this am "True or False Phenobarbital is an Ingredient in Concordia's Drug Donnatel? Is that a problem given it was never approved by the FDA?"  trying to instill fear when not warranted.  see below for your reference of why FDA approval is not a problem. Same tricks every time

See slide 45 from FDA presentation:
https://www.fda.gov/downloads/AboutFDA/WorkingatFDA/FellowshipInternshipGraduateFacultyPrograms/PharmacyStudentExperientialProgramCDER/UCM253386.pdf

and
https://compoundingtoday.com/Compliance/FDAPre1938Drugs.cfm
Comment by visionaryfool on Jun 08, 2016 9:38am
FDFD... care to tweet this to Chodes? see what he says?
Comment by fdfd12 on Jun 08, 2016 9:51am
tweet what?
Comment by visionaryfool on Jun 08, 2016 9:58am
Tweet this why its not a problem for Phenobarbital.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities